Clinical Trials Sponsored by Kyle Knight

Total 758 results

OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm | Malignant Thoracic Neoplasm | Malignant Head and Neck Neoplasm | Malignant Breast Neoplasm

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Available

Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders

Malignant Neoplasm | Hematopoietic Cell Transplantation Recipient | Benign Neoplasm | Bone Marrow Transplantation Recipient

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Withdrawn

Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Unresectable Hepatocellular Carcinoma | Recurrent Hepatocellular Carcinoma | BCLC Stage B Hepatocellular Carcinoma | BCLC Stage C Hepatocellular Carcinoma | Locally Advanced Hepatocellular Carcinoma
OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

A Digital Intervention Protocol to Enhance Recovery After Head and Neck Surgery

Head and Neck Carcinoma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

Effects of Simulated Solar Radiation on Human Skin in Preventing Skin Cancer

Melanoma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Active, not recruiting

Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors

Malignant Glioma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma

Glioblastoma

United States
Oregon Health and Science University
OHSU Knight Cancer Institute

Withdrawn

Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)

COVID-19 | SARS-CoV-2

United States
OHSU Knight Cancer Institute
National Institutes of Health (NIH)

Completed

CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening

Cervical Cancer | Breast Cancer | Colorectal Cancer

United States
Light Sciences Oncology

Completed

Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Carcinoma, Hepatocellular | Liver Neoplasms

Taiwan, Hong Kong, Singapore
Boston Sight

Withdrawn

Novel Use of Restasis and PROSE Devices

Ocular Surface Disease

United States
Philadelphia Fight

Completed

PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color

HIV

United States
Wright State University

Not yet recruiting

Sphenopalatine Ganglion Block and Cold Induced Headaches

Headache | Cold Induced Headache | Brain Freeze | Cold Induced Cephalgia
Bright Cell, Inc.

Not yet recruiting

Safety and Efficacy of YB-1113 in Treatment of POI

POI
Wright State University

Recruiting

Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis

Plaque Psoriasis | Vitamin D3

United States
Wright State University

Recruiting

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

Aging | Actinic Keratoses | Non-Melanoma Skin Cancer

United States
Wright State University

Completed

Photodynamic Therapy-Induced Immune Modulation: Part III

Actinic Keratosis | Photodynamic Therapy

United States
Wright State Physicians

Completed

Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Healthy Adult Male Subjects

Allergic Contact Dermatitis

United States
Wright State University

Completed

UVB-Induced MVP Release in Human Skin

Ultraviolet B Radiation | Microvesicle Particles

United States
Research Insight LLC

Completed

The DEPOT Study (Dry Eye Prescription Options for Therapy)

Dry Eye

United States
Research Insight LLC

Completed

Vivity Insight: A Study of Patient Satisfaction and Visual Performance

Cataract

United States
Research Insight LLC

Completed

Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery

Dry Eye Syndromes

United States
Research Insight LLC

Completed

A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%

Cataract

United States
Wright State University

Withdrawn

Liposomal Bupivacaine After Cesarean Delivery

Pain, Postoperative | Opioid Use

United States
Research Insight LLC

Completed

Comparison of Pre-operative Measurements With Intraoperative Aberrometry in Predicting Correction for Low Toric Lens Correction in Cataract Surgery

Cataract Surgery

United States
Rabin Medical Center
Night Sense Ltd

Completed

Development and Assessment of Feasibility of Non-invasive Multiple Sensor Hypo-Sense as a Tool for Detection of Hypoglycemia (Hypo-Sense)

Type 1 Diabetes | Nocturnal Hypoglycemia

Israel
OHSU Knight Cancer Institute
AstraZeneca; Oregon Health and Science University

Recruiting

Olaparib in Combination With Either Durvalumab, Selumetinib, or Capivasertib or Ceralasertib Alone in Treating Patients With Metastatic Triple Negative Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma

United States
OHSU Knight Cancer Institute
Sanofi; Oregon Health and Science University

Active, not recruiting

Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
OHSU Knight Cancer Institute
AstraZeneca; Oregon Health and Science University

Completed

Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Stage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7

United States
OHSU Knight Cancer Institute
Bayer; Oregon Health and Science University

Completed

Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma

Pleomorphic Rhabdomyosarcoma | Stage III Adult Soft Tissue Sarcoma AJCC v7 | Stage IV Adult Soft Tissue Sarcoma AJCC v7 | Stage IIB Adult Soft Tissue Sarcoma AJCC v7

United States
OHSU Knight Cancer Institute
Novartis; Oregon Health and Science University

Not yet recruiting

177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Breast Carcinoma

United States
OHSU Knight Cancer Institute
Susan G. Komen Breast Cancer Foundation

Completed

Strength Training for Older Breast Cancer Survivors

Breast Neoplasm | Osteoporosis, Postmenopausal

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); medac GmbH

Completed

Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

United States
Boston Sight

Completed

Tonometry Precision and Accuracy During PROSE Scleral Lens Wear: A Pilot Study

Intraocular Pressure and PROSE Lens

United States
Sight Diagnostics

Completed

Analytical and Clinical Performance Testing Plan

Hematology | Hematologic Test

United States
OHSU Knight Cancer Institute
AbbVie; Oregon Health and Science University

Recruiting

Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia

B Acute Lymphoblastic Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Mixed Phenotype Acute Leukemia

United States
University of Minnesota
General Mills; Tate and Lyle Ingredients France

Completed

Laxation and Satiety Response of Novel Dietary Fibers

Healthy

United States
Infraredx
Bright Research Partners

Completed

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon (EXPANSE-PTCA)

Coronary Stenosis | Coronary Artery Stenosis | In-stent Restenosis

United States
Church & Dwight Company, Inc.

Completed

Sterimar Allergic Rhinitis

Allergic Rhinitis

Armenia
Church & Dwight Company, Inc.

Completed

Clinical Evaluation of the Efficacy of a Marketed Dentifrice on Plaque and Gingivitis

Gingivitis | Plaque

Canada
Molecular Insight Pharmaceuticals, Inc.

Approved for marketing

Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Church & Dwight Company, Inc.

Completed

A Single-Center, Clinical Study to Evaluate the Safety of a New Personal Lubricant in Healthy Female Subjects

Edema | Erythema

United States
Church & Dwight Company, Inc.

Completed

14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin - Chameleon

Dermal Irritation

United States
Church & Dwight Company, Inc.

Completed

A Single-Center, Clinical Study to Evaluate the Safety of a Non-Fragranced Personal Lubricant in Healthy Female Subjects

Edema | Erythema

United States
Church & Dwight Company, Inc.

Completed

14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin

Cumulative Irritation

United States
Church & Dwight Company, Inc.

Completed

Repeated Insult Patch Test of Personal Lubricants

Edema | Erythema
Molecular Insight Pharmaceuticals, Inc.

Completed

Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome (Zeus-ACS)

Acute Coronary Syndrome

United States, Canada
Molecular Insight Pharmaceuticals, Inc.

Withdrawn

Study to Evaluate the Efficacy and Safety of 90Y-SMT487 in Subjects With Symptomatic Malignant Carcinoid Tumors

Malignant Carcinoid Tumor
Molecular Insight Pharmaceuticals, Inc.

Completed

Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection

Prostate Cancer

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404

Prostate Cancer

United States

Clinical Trials Sponsored by Kyle Knight

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations